North America’s medical devices industry saw a drop of 32.14% in deal activity during May 2022, when compared with the last 12-month average, led by ConMed ’s $255m acquisition of In2Bones Global , according to GlobalData’s deals database.
- Embed this chart
Embed this chart into your website
Copy and paste the image source into your website to display the chart.
A total of 76 medical devices industry deals worth $866.4m were announced for the region in May 2022, against the 12-month average of 112 deals.
Of all the deal types, venture financing saw most activity in May 2022 with 51 transactions, representing a 67.1% share for the region.
In second place was M&A with 19 deals, followed by private equity deals with six transactions, respectively capturing a 25% and 7.9% share of the overall deal activity for the month.
In terms of value of deals, venture financing was the leading category in North America’s medical devices industry with $534.86m, while M&A and private equity deals totalled $271.5m and $60m, respectively.
North America medical devices industry deals in May 2022: Top deals
The top five medical devices deals accounted for 56% of the overall value during May 2022.
The combined value of the top five medical devices deals stood at $485m, against the overall value of $866.4m recorded for the month.
The top five medical devices industry deals of May 2022 tracked by GlobalData were:
1) ConMed $255m acquisition deal with In2Bones Global
2) The $70m venture financing of Hello Heart by BlueRun Ventures,Institutional Venture Partners,Maven Ventures,Resolute Ventures and Stripes Group
3) Dubilier & Rice and Clayton $60m private equity deal with Cynosure
5) Acrew Capital,Bold Capital Partners,GGV Capital,Gilead Sciences,Industry Ventures,Positive Sum,World Innovation Lab and Xfund $40m venture financing deal with Curebase